Zobrazeno 1 - 10
of 470
pro vyhledávání: '"Won‐Sik Lee"'
Autor:
Changhee Park, Ho Sup Lee, Ka-Won Kang, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok-Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung-Soo Yoon, Youngil Koh
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the authors report a single-arm phase II clinical trial of combination of acalabrutinib,
Externí odkaz:
https://doaj.org/article/1be364a2c8774becbc1348fb645041c5
Autor:
Dong Won Baek, Han-Seung Park, Sang Kyun Sohn, Dae Young Kim, Inho Kim, Jae-Sook Ahn, Young Rok Do, Se Ryeon Lee, Hyeon-Seok Eom, Won-Sik Lee, Sung-Hyun Kim, Ho Sup Lee, Yoo Jin Lee, Joon Ho Moon, Je-Hwan Lee, Adult Acute Lymphoblastic Leukemia Working Party, the Korean Society of Hematology
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 5, Pp 734-746 (2023)
Background/Aims We performed a prospective study to determine the efficacy and safety of rituximab including chemotherapy in CD20-positive acute lymphoblastic leukemia (ALL). Methods Patients with newly diagnosed ALL, aged ≥ 15 years, were eligible
Externí odkaz:
https://doaj.org/article/35144df3d4e9443393e6fddb24e41b02
Autor:
Yu Ri Kim, Ho Jin Shin, Ho-Young Yhim, Deok-Hwan Yang, Yong Park, Ji Hyun Lee, Won-Sik Lee, Young Rok Do, Yeung-Chul Mun, Dae Sik Kim, Jin Seok Kim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundBone marrow (BM) involvement is an indicator of a poor prognosis in diffuse large B-cell lymphoma (DLBCL); however, few studies have evaluated the role of immunoglobulin gene rearrangement (IgR) in detecting BM involvement.MethodsWe evaluat
Externí odkaz:
https://doaj.org/article/45cd96a278aa4d918d0f215ef45bf304
Autor:
Ga-Young Song, Je-Jung Lee, Joon Ho Moon, Dajung Kim, Min Kyoung Kim, Hyo Jung Kim, Yeung-Chul Mun, Won-Sik Lee, Young Rok Do, Jae Hoon Lee, Sung-Hoon Jung, Jin Seok Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionPegylated granulocyte colony-stimulating factor (G-CSF) has been widely used for preventing febrile neutropenia in various types of cancer treatment. In the present study, we prospectively evaluated the safety and efficacy of pegfilgrasti
Externí odkaz:
https://doaj.org/article/73a947a4b435409a9077f946b48e17da
Autor:
Sung‐Yong Kim, Won‐Sik Lee, Sung Yong Oh, Deok‐Hwan Yang, Hyo Jung Kim, Seong Kyu Park, Jae Wook Yang, Suk‐Woo Yang, Seok‐Goo Cho
Publikováno v:
Cancer Medicine, Vol 11, Iss 14, Pp 2817-2823 (2022)
Abstract Background Approximately 50% of limited‐stage ocular adnexal mucosa‐associated lymphoid tissue lymphoma (OAML) patients with adverse prognostic factors relapse after radiotherapy. Chemoimmunotherapy has been proposed as an alternative fr
Externí odkaz:
https://doaj.org/article/65d858d513ba4995950d621221b22bd1
Autor:
Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, Won-Sik Lee, In-Ho Kim, Yeung-Chul Mun, Gi June Min, Ki-Seong Eom, Seok-Goo Cho
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundA chemotherapy of rituximab, fludarabine and cyclophosphamide (R-FC) has been accepted as a promising frontline chemotherapy in selected patients with chronic lymphocytic leukemia (CLL). Although R-FC regimen is a relatively dose-dense regi
Externí odkaz:
https://doaj.org/article/9f7b900f3cdc4292a9d9e4e7c2b615a9
Autor:
Sang Eun Yoon, Yuqin Song, Seok Jin Kim, Dok Hyun Yoon, Tsai-Yun Chen, Youngil Koh, Ka Won Kang, Ho Sup Lee, Kevin Kuang Wei Tay, Soon Thye Lim, Michele Poon, Cosphiadi Irawan, Weili Zhao, Young Rok Do, Mark Hong Lee, Soo Chin Ng, Won-Sik Lee, Ye Guo, Huilai Zhang, Hye Jin Kang, Hwan Jung Yun, Hyo Jung Kim, Daryl Tan Chen Lung, Jae-Yong Kwak, Jae Joon Han, Yeung-Chul Mun, Sung Yong Oh, Hyeok Shim, Jung Hye Kwon, Byeong Seok Sohn, Seong Kyu Park, Jae-Cheol Jo, Young Hyeh Ko, Zhu Jun, Won Seog Kim
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 10, Iss , Pp 100126- (2021)
Background: Peripheral T-cell lymphomas (PTCLs) are uncommon and their frequency is regionally heterogeneous. Several studies have been conducted to evaluate the clinical features and treatment outcomes of this disease entity, but the majority of the
Externí odkaz:
https://doaj.org/article/7bd9491e02234f29aebb00e8c11f836c
Autor:
Jae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, Hana Jung, Anbok Lee, Ji-Young Lee, Joo Yeon Song, Seung Jae Park, Ilhwan Kim, Won-Sik Lee, Su-Kil Seo, Il-Whan Choi, Yang-Xin Fu, Sung Su Yea, SaeGwang Park
Publikováno v:
OncoImmunology, Vol 7, Iss 5 (2018)
Combination therapies with phosphoinositide 3-kinase (PI3K) inhibitors and trastuzumab (anti-human epidermal growth factor receptor [HER]2/neu antibody) are effective against HER2+ breast cancer. Isoform-selective PI3K inhibitors elicit anti-tumor im
Externí odkaz:
https://doaj.org/article/864966d7ab1c4922b49706a444b686d8
Publikováno v:
Sensors, Vol 16, Iss 5, p 664 (2016)
In this study, we classify four horse gaits (walk, sitting trot, rising trot, canter) of three breeds of horse (Jeju, Warmblood, and Thoroughbred) using a neuro-fuzzy classifier (NFC) of the Takagi-Sugeno-Kang (TSK) type from data information transfo
Externí odkaz:
https://doaj.org/article/fecbecc9131549c395f8c9c91aa451f1
Autor:
Ho-Jin Shin, Do-Young Kim, Kihyun Kim, Chang-Ki Min, Je-Jung Lee, Yeung-Chul Mun, Won-Sik Lee, Sung-Nam Lim, Jin Seok Kim, Joon Ho Moon, Da Jung Kim, Soo-Mee Bang, Jong-Ho Won, Jae-Cheol Jo, Young Il Koh
Publikováno v:
Cancer Research & Treatment; Jul2024, Vol. 56 Issue 3, p956-966, 11p